publicações selecionadas documento Hexokinase II (HKII) as prognostic biomarker and target for bladder cancer therapy 2022 Metabolic remodelling in cisplatin-resistant bladder cancer 2020 Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming 2019
